The Federal Circuit affirmed the decision of the Patent Trial and Appeal Board that challenged claims of Medmix Switzerland AG’s patent directed to an arrangement for mixing and discharging fluids are unpatentable as obvious over prior art, in an inter partes review by Xinial Sys. GmbH & Co. KG. The court determined that the board’s didn’t err in its claim construction, and found that its motivation-to-combine findings were supported by substantial evidence.
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.